Gaughran, F., Stringer, D., Berk, M., Smith, S., Taylor, D., Whiskey, E., Landau, S., Murray, R., McGuire, P., Gardner-Sood, P., Wojewodka, G., Ciufolini, S., Jordan, H., Clarke, J., Allen, L., Krivoy, A., Stubbs, B., Lowe, P., Arbuthnott, M.
... McGrath, J. J. (2020).
Vitamin D supplementation compared to placebo in people with First Episode psychosis - Neuroprotection Design (DFEND): a protocol for a randomised, double-blind, placebo-controlled, parallel-group trial.
Trials,
21(1), Article 14.
https://doi.org/10.1186/s13063-019-3758-9Gooch, H., Cui, X., Anggono, V., Trzaskowski, M., Tan, M. C., Eyles, D. W., Burne, T. H. J., Jang, S. E.
, Mattheisen, M., Hougaard, D. M., Pedersen, B. N., Cohen, A.
, Mortensen, P. B., Sah, P.
& McGrath, J. J. (2019).
1,25-Dihydroxyvitamin D modulates L-type voltage-gated calcium channels in a subset of neurons in the developing mouse prefrontal cortex.
Translational Psychiatry,
9(1), Article 281.
https://doi.org/10.1038/s41398-019-0626-z